Eyepoint Pharmaceuticals

U.S. stocks experienced a downturn on Monday, with significant indices reflecting a bearish trend. The Dow Jones Industrial Average slightly dipped by 0.11% to 36,204.44, while the NASDAQ Composite saw a more pronounced fall of 0.84% to 14,185.49. The S&P 500 also followed suit, dropping by 0....

Sign up for this week’s All Access giveaway here!  Nancy Lurker, President and CEO of EyePoint Pharmaceuticals (NASDAQ: EYPT), was a guest on Benzinga’s All Access on September 30, 2022. EyePoint is a pharmaceutical company developing and commercializing therapeutics to help...

Photo Credit: EyePoint Pharmaceuticals   The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Companies dedicated to improving the lives of the 2.2 billion people suffering from eye...